GOSS

0.9414

3.79% -0.0371

After Hours: .92 -0.0214 -2.27%

Gossamer Bio Inc (GOSS)

Overview News Price History Option Chain Financials Discussions Forecast

Gossamer Bio Inc stock is traded at $0.9414, with a volume of 1.27M. It is down -3.79% in the last 24 hours and down -20.22% over the past month.

Previous Close:

$0.9785

Open:

$0.9493

24h Volume:

1.27M

Relative Volume:

0.89

Market Cap:

$213.91M

Revenue:

Net Income/Loss:

$-179.82M

P/E Ratio:

-0.7078

EPS:

-1.33

Net Cash Flow:

$-159.16M

1W Performance:

-18.84%

1M Performance:

-20.22%

6M Performance:

-6.79%

1Y Performance:

-15.19%

1-Day Range:

$0.915

$0.9735

1-Week Range:

$0.915

$1.22

52-Week Range:

$0.4993

$1.55

Gossamer Bio Inc Stock (GOSS) Company Profile

Name

Gossamer Bio Inc

Sector

Healthcare (1182)

Industry

Biotechnology (678)

Phone

(858) 684-1300

Address

3115 MERRYFIELD ROW, SAN DIEGO, CA

Employee

Twitter

@GossamerBio

Next Earnings Date

2024-11-07

Latest SEC Filings

GOSS's Discussions on Twitter

Compare GOSS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GOSS Gossamer Bio Inc	0.9414	213.91M	0	-179.82M	-159.16M	-1.33
VRTX Vertex Pharmaceuticals Inc	484.01	124.29B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	610.64	68.39B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	590.06	35.99B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	262.16	33.93B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	264.32	28.47B	3.81B	-644.79M	-669.77M	-6.24

Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-25-24	Initiated	Oppenheimer	Outperform
Apr-05-24	Resumed	Wedbush	Outperform
Jul-27-23	Downgrade	UBS	Buy → Neutral
Mar-07-23	Downgrade	Raymond James	Outperform → Mkt Perform
Mar-01-23	Initiated	Guggenheim	Neutral
Dec-07-22	Downgrade	Barclays	Overweight → Equal Weight
Dec-07-22	Downgrade	JP Morgan	Neutral → Underweight
Dec-07-22	Downgrade	SMBC Nikko	Outperform → Neutral
Oct-20-22	Initiated	Goldman	Buy
Sep-21-22	Initiated	JP Morgan	Neutral
Sep-19-22	Initiated	Wedbush	Outperform
Apr-18-22	Initiated	Raymond James	Outperform
Apr-06-22	Initiated	UBS	Buy
Jan-10-22	Upgrade	SMBC Nikko	Neutral → Outperform
Nov-09-21	Resumed	Cantor Fitzgerald	Overweight
Sep-21-21	Resumed	Piper Sandler	Overweight
Jun-29-20	Initiated	H.C. Wainwright	Buy
Apr-22-20	Initiated	Piper Sandler	Overweight
Feb-27-20	Initiated	Barclays	Overweight
Dec-03-19	Resumed	BofA/Merrill	Buy
Oct-30-19	Initiated	Berenberg	Buy
Mar-05-19	Initiated	Barclays	Overweight
Mar-05-19	Initiated	BofA/Merrill	Buy
Mar-05-19	Initiated	Evercore ISI	Outperform
Mar-05-19	Initiated	SVB Leerink	Outperform

View All

Gossamer Bio Inc Stock (GOSS) Latest News

Mar 31, 2025

Charles Schwab Investment Management Inc. Raises Stock Position in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

Mar 31, 2025

Mar 27, 2025

Is Gossamer Bio Inc. (GOSS) the Popular Penny Stock on Robinhood to Watch? - MSN

Mar 27, 2025

Cantor Fitzgerald Comments on Gossamer Bio FY2025 Earnings - Defense World

Mar 27, 2025

Mar 26, 2025

Is Gossamer Bio, Inc. (GOSS) The Hot Biotech Stock Under $5? - Insider Monkey

Mar 26, 2025

Gossamer Bio Inc (NASDAQ: GOSS) Analysts Think Could Fell -290.62% From Current Levels - Stocks Register

Mar 26, 2025

Mar 23, 2025

Gossamer Bio (GOSS): Among the Penny Stocks With Huge Upside Potential According to Analysts - Yahoo Finance

Mar 23, 2025

Gossamer Bio, Inc. (NASDAQ:GOSS) Position Decreased by Victory Capital Management Inc. - Defense World

Mar 23, 2025

Mar 22, 2025

10 Penny Stocks With Huge Upside Potential According To Analysts - Insider Monkey

Mar 22, 2025

Mar 21, 2025

GOSSAMER BIO Earnings Preview: Recent $GOSS Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 19, 2025

Mar 18, 2025

H.C. Wainwright maintains Buy on Gossamer Bio, $10 target By Investing.com - Investing.com South Africa

Mar 18, 2025

H.C. Wainwright maintains Buy on Gossamer Bio, $10 target - Investing.com

Mar 18, 2025

Mar 16, 2025

Wedbush Reiterates Outperform Rating for Gossamer Bio (NASDAQ:GOSS) - Defense World

Mar 16, 2025

Mar 15, 2025

Gossamer Bio Reports 2024 Financial Results and Progress - TipRanks

Mar 15, 2025

Mar 14, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 14, 2025

Gossamer Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 14, 2025

Mar 13, 2025

Gossamer Bio shares rise on Q4 earnings beat By Investing.com - Investing.com South Africa

Mar 13, 2025

Gossamer Bio shares rise on Q4 earnings beat - Investing.com India

Mar 13, 2025